Net worth tracking
Login Sign Up
Become a Premium Member
  • All Opinions
  • Top Picks
  • Experts
  • Companies
  • Discover
Watch List
Home » Stock Lists

Battle of the Top Dividend ETFs : Canada

Allan Tong Posted On November 26, 2019
0
0
Shares
  • Share On Facebook
  • Tweet It

This week we’re marrying two popular stories–Battle of the Stocks and ETFs—into one.

Canadian ETFs to invest the world

We’re pitting pairs of ETFs that cover Canada, the U.S. and the rest of the world (including emerging markets) against each other. To avoid any tax issues, we’re looking at Canadian ETFs only, nothing from the Nasdaq or S&P. To sweeten the pot, we’re focusing on dividend ETFs in Canada and America.

Here we go:

Canadian dividend ETFs

ZDV-T vs. XEI-T

ZDV (the BMO Canadian Dividend ETF) pays a 4.9% dividend yield (paid monthly), charges a 0.38% MER, and counts Enbridge, National Bank, CIBC, SunLife, Power Corp, Manulife and Inter Pipeline among its top holdings.

These holdings are ranked according to dividend growth and payout ratio. Mike Philbrick warns that ZDV is more volatile than others, underperforming the market in 2018. Mike Newton echoes this concern, but is generally positive on this ETF for its yield and low fee. Richard Croft and Larry Berman like ZDV more, for giving Canadian investors exposure to telcos, pipelines and utilities to balance the banks.

ZDV is Daniel Straus‘s favourite dividend ETF, but warns against putting it into an RRSP to avoid a tax hit.

XEI (the iShares S&P/TSX Composite High Dividend Index ETF ) pays a 4.91% dividend yield (paid monthly), charges a 0.22% MER, and counts Enbridge, CIBC, Manulife, BMO, Bank of Nova Scotia, TC Energy, CNQ-T and BCE among its top holdings, with each holding capped at 5% and each sector limited to 30%.

John Hood likes XEI for its sector diversity, a virtue also found in the ZDV. Both ETFs pay the same dividend, but XEI charges a much lower management fee and its volume is a little heavier at over 21,500 shares per day (over 17,000 for ZDV). However, Tyler Mordy warns that XEI includes high-divdend payers, which is great for income, but volatile if an individual company’s yield grows too high–and unsustainable.

Year-to-date, XEI edges out ZDV by a fraction of a percentage point, though both lag the TSX  by a hair. However, factor in the dividends and both ETFs soundly beat the index.

Verdict: Both are income ETFs with some volatility risk, but XEI wins for its lower MER and slightly better performance.

American dividend ETDs

XHD-T vs. ZDY-T

XHD (the iShares U.S. High Dividend Equity Index ETF) pays a 2.63% dividend yield, charges a 0.33% MER, and includes AT&T, Exxon, Johnson & Johnson, Verizon and Wells Fargo among its top holdings.

XHD is hedged to the Canadian-dollar, which could help or hurt you depending on the fluctuation of the American greenback, warns Daniel Straus. He endorses XHD for picking American companies that are protected by a wide moat.

However, volume is light, averaging over only 1,885 shares per day.

ZDY (the BMO U.S. Dividend ETF) pays a 2.98% dividend yield (paid monthly), charges a 0.32% MER, and lists AT&T, Wells Fargo, Philip Morris, AbbVie, IBM, Amgen and Broadcom as its top holdings.

These holdings boast stable or rising dividends The key difference between this and XHD is that ZDY is not hedged. ETF specialist Berman explains that if you think the CAD will get stronger, then buy a hedged ETF (e.g. ZDY).

If you believe the American greenback will grow stronger, then stick with ZDY. If you feel that American markets are rotating to value stocks, then go with ZDY, adds Stan Wong. Otherwise, ZDY does the job, says John Degoey.

Year-to-date, ZDY has outperformed XHD 13.5% to 12.7%. ZDY also boasts a higher average volume of 5,800.

Verdict: ZDY. The dividend pays slightly more than XHD, but the kicker is the currency hedging. The street consensus is that the Yankee dollar will rise going forward (and/or the CAD will slip).

International dividend ETF

ZDI-T vs. VEE-T

ZDI (the BMO International Dividend ETF ) pays a 5.11% dividend yield (paid monthly), charges a 0.43% MER, and carries Total, Basf, Bayer, ING and Sanofi among its top holdings. Despite its name, ZDI is basically a European ETF, so it comes down to your outlook on Europe. Myself, I’m cold, given the Brexit soap opera and troubles in countries like Italy, but diversity is crucial to any portfolio with emerging markets comprising around 22% of world markets.

Another issue is that international dividend ETFs on the TSX are few and far between. There’s a new player, VIDY-T, but it’s hardly ever trading, averaging 1 share per day! A better comparative is the non-dividend ETF, VEE-T (the Vanguard FTSE Emerging Markets All Cap Index ETF ), which trades in tandem with ZDI over the past year, but leaves ZDI in the dust, rising 18% over five years compared to ZDI’s 7.5%. Mind you, VEE pays a lower dividend of 2.2%, but also charges a lower MER at 0.23%.

John DeGoey loves VEE for its broad diversity and long-term performance. John Hood gives it another thumbs-up, but advises limiting exposure, given how the U.S. still pays better returns.

However, Berman doesn’t like VEE for omitting lucrative South Korea.

Verdict: ZDI is a dividend ETF and VEE is not, so the playing field isn’t level. Rather these are two ways to play E.M., one covering European dividends, and the other playing the much broader world at a lower distribution but also cost. Which one is right for you depends on your outlook of each territory and whether you want income (ZDI) or a long-term investment (VEE).

0
Shares
  • Share On Facebook
  • Tweet It




Trending Now
Transalta Corp, Winpak Ltd. and More at 52-week Highs & Lows (Jun 29-Jul 05)
Melisa R. H. July 6, 2022
3 defensive stocks weather uncertain markets
Allan Tong July 5, 2022
You may also like
Coronavirus Stock Market Scare: What Stocks to Buy?
January 28, 2020
International Stocks: Looking Ahead to 2020
December 10, 2019
Happy Friday on Toronto and New York markets
December 6, 2019
Read Next

Alibaba IPO the biggest of 2019 as U.S. Attorney subpoenas big pharma

  • We're the Stock Chasers
    Hi! We are the Stock Chasers. We write about investing and finance tools we love. We’re passionate about fintech and we invest almost all our affiliate and advertising revenues into the development of Stockchase and Wealthica. We hope you enjoy the stock ideas and product reviews!
  • Top Reviews

    • Questrade Review: Pros & Cons of Trading with Questrade Canada (2021)
      8.5
    • Questrade vs Others | The Review Competitors Don’t Want you to Read (2021)
      7.4
    • The Ugly Truth About Identity Theft – Free Credit Report
      7
  • Popular Posts

    • Transalta Corp, Winpak Ltd. and More at 52-week Highs & Lows (Jun 29-Jul 05)
    • 3 defensive stocks weather uncertain markets
    • HTC Purenergy Inc., Velan Inc and More Earnings Reports this Week (Jul 04-08)
    • FedEx, Aritzia Inc. and 17 Stock and 3 ETF Top Picks (Jun 24-30)
    • 3 gems from the Collision technology conference
  • Stock Lists

    • 3 defensive stocks weather uncertain markets
      July 5, 2022
    • 3 defensive stocks to find stability with your money
      June 21, 2022
    • 3 rock stars of the mineral stocks
      June 15, 2022
    • 3 stocks to profit from revenge travel
      June 7, 2022
    • Are tech stocks alive?
      May 31, 2022


  • Get $50 in free trades.


  • Stockchase neither recommends nor promotes any investment strategies.

    About us : Privacy & Terms : Contact us

© Stockchase Inc.
Press enter/return to begin your search